BIOTON S.A. (WSE:BIO)
Poland · Delayed Price · Currency is PLN 3.845
0.00 (0.00%)
Jul 24, 2026, 5:00 PM CET
BIOTON Market Cap
BIOTON has a market cap or net worth of 330.15 million as of July 24, 2026. Its market cap has decreased by -6.22% in one year.
Market Cap
330.15M
Enterprise Value
386.28M
Revenue
266.02M
Ranking
n/a
PE Ratio
81.63
Stock Price
3.85
ChartMarket Cap Chart
Since July 1, 2005, BIOTON's market cap has decreased from 1.09B to 330.15M, a decrease of -69.80%. That is a compound annual growth rate of -5.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 330.15M | -0.39% |
| Dec 30, 2025 | 331.44M | 33.80% |
| Dec 30, 2024 | 247.72M | -19.19% |
| Dec 29, 2023 | 306.54M | 5.93% |
| Dec 30, 2022 | 289.36M | -19.47% |
| Dec 30, 2021 | 359.34M | -2.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 589.22M |
| Bioceltix | 542.16M |
| Captor Therapeutics Spolka Akcyjna | 479.05M |
| Ryvu Therapeutics | 349.58M |
| Synthaverse | 210.64M |
| Poltreg | 136.08M |
| Molecure | 122.59M |
| Mabion | 118.47M |